ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHUPLSK....................................JBDM Ver 0.1.59 (03 Mar 2017) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification2520654CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120170419W173deBibliographieenBibliographyfrBibliographieEP12003146.3200408262012050220131120enenen497703 P20030826US2017041920171620121107201245201702012017052016080320170419201716C12N 15/62 20060101AFI20150616BHEP C07K 14/81 20060101ALI20150616BHEP C07K 16/00 20060101ALI20150616BHEP A61K 38/57 20060101ALI20150616BHEP deSerinprotease-Hemmer und deren Verwendung in Verfahren und Zusammensetzungen für die Behandlung bakterieller InfektionenenInhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infectionsfrInhibiteurs de l'activité de sérine protéase et leur utilisation dans des procédés et compositions pour le traitement des infections bactériennesWO-A1-01/03737WO-A1-92/06706WO-A2-00/51623WO-A2-02/060919WO-A2-03/059935US-B1- 6 287 817CHAN E D ET AL: "Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages", SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, SCANDINAVIAN UNIVERSITY PRESS, OSLO, NO, vol. 39, no. 8, 1 January 2007 (2007-01-01), pages 690-696, XP008108498, ISSN: 0036-5548, DOI: 10.1080/0036554070122574404801916.016600942004082617000155.620170131Shapiro, Leland8765 E. 29th PlaceDenver, CO 80220USThe Regents of the University of Colorado, a body corporate101525368U10050EP/D-I1800 Grant Street, 8th FloorDenver, CO 80203USBohmann, Armin K.100046635Bohmann Anwaltssozietät Nymphenburger Straße 180335 MünchenDEATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEITLILUMCNLPLPTROSESISKTR20121107201245